MicroRNA regulation of macrophage polarization in lung cancer: Regulatory networks and therapeutic potential (Review)

Ji Y, Zhang Y, Liu S, Li J, Jin Q, Wu J, Duan H, Liu X, Yang L and Huang Y: The epidemiological landscape of lung cancer: Current status, temporal trend and future projections based on the latest estimates from GLOBOCAN 2022. J Natl Cancer Cent. 5:278–286. 2025.PubMed/NCBI

Passaro A, Brahmer J, Antonia S, Mok T and Peters S: Managing resistance to immune checkpoint inhibitors in lung cancer: Treatment and novel strategies. J Clin Oncol. 40:598–610. 2022. View Article : Google Scholar : PubMed/NCBI

Xiao M, He J, Yin L, Chen X, Zu X and Shen Y: Tumor-associated macrophages: Critical players in drug resistance of breast cancer. Front Immunol. 12:7994282021. View Article : Google Scholar

Peng H, Xian D, Liu J, Pan S, Tang R and Zhong J: Regulating the polarization of macrophages: A promising approach to vascular dermatosis. J Immunol Res. 2020:81482722020. View Article : Google Scholar : PubMed/NCBI

Hu Y, Tang J, Sun H, Li Y, Yu F, Zhang G, Chen J, Xu H, Zhong Z, Huang C, et al: Artesunate modulates the tumor microenvironment via STAT1/IRF1-mediated TAM repolarization and T cell activation in non-small cell lung cancer. Phytomedicine. 146:1570852025. View Article : Google Scholar : PubMed/NCBI

Yu H, Zhang J, Liu Q, Liu L, Le Y, Cen H, Peng W, Wei J, Liu S, Qin A, et al: Biomimetic proteolipid vesicles delivering small activating RNA to activate the macrophage immunotherapy for the treatment of lung cancer. J Nanobiotechnology. 24:5082026. View Article : Google Scholar : PubMed/NCBI

Chengzhi W, Songwei L, Yifan L, Mengmeng D and Huan L: The role of microRNAs in primary Sjögren's disease: Deciphering regulatory networks and assessing current therapeutic perspectives. Front Immunol. 16:16693822025. View Article : Google Scholar

Wang Y, Chen W, Yu B, Wang L and Tang W: Exosomal miR-93-5p modulates macrophage polarization to enhance prostate cancer progression. Arch Biochem Biophys. 779:1107532026. View Article : Google Scholar : PubMed/NCBI

Bartoszewska E, Misiąg P, Czapla M, Rakoczy K, Tomecka P, Filipski M, Wawrzyniak-Dzierżek E and Choromańska A: The role of microRNAs in lung cancer: Mechanisms, diagnostics and therapeutic potential. Int J Mol Sci. 26:37362025. View Article : Google Scholar : PubMed/NCBI

Huang Q, Chu X, Yang C, Huai Y, He C, Ma X, Pei J, Gao J, Liu Z, Jiang S, et al: Bio-engineered microRNA-7 effectively interferes with the Akt3/p53 axis to suppress human non-small cell lung cancer. Cancer Cell Int. 25:2502025. View Article : Google Scholar : PubMed/NCBI

Deng J and Wu M: COX10-AS1-mediated miR-361-5p regulated cell invasion and migration by targeting SPRY1 in oral squamous cell carcinoma. Am J Transl Res. 15:2191–2206. 2023.PubMed/NCBI

Steadman K, You S, Srinivas DV, Mouakkad L, Yan Y, Kim M, Venugopal SV, Tanaka H and Freeman MR: Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3'untranslated region. Front Cell Dev Biol. 11:12062592023. View Article : Google Scholar

Song K and Artibani M: The role of DNA methylation in ovarian cancer chemoresistance: A narrative review. Health Sci Rep. 6:e12352023. View Article : Google Scholar : PubMed/NCBI

Lu TX and Rothenberg ME: MicroRNA. J Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar

El Founini Y, Chaoui I, Dehbi H, El Mzibri M, Abounader R and Guessous F: MicroRNAs: Key regulators in lung cancer. Microrna. 10:109–122. 2021. View Article : Google Scholar : PubMed/NCBI

Geekiyanage H, Rayatpisheh S, Wohlschlegel JA, Brown R and Ambros V: Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides. Proc Natl Acad Sci USA. 117:24213–24223. 2020. View Article : Google Scholar : PubMed/NCBI

Shanehbandi D, Asadi M, Seyedrezazadeh E, Zafari V, Shekari N, Akbari M, Rahbarnia L and Zarredar H: MicroRNA-based biomarkers in lung cancer: Recent advances and potential applications. Curr Mol Med. 23:648–667. 2023. View Article : Google Scholar

Liu J, Wang W, Wang K, Liu W, Zhao Y, Han X, Wang L and Jiang BH: HDAC1 and FOXK1 mediate EGFR-TKI resistance of non-small cell lung cancer through miR-33a silencing. J Transl Med. 22:7932024. View Article : Google Scholar : PubMed/NCBI

Shintani T, Shun YT, Toyozumi Y, Ikemura K, Shiroyama T, Nagatomo I, Jingushi K, Takeda Y, Kumanogoh A and Okuda M: MicroRNA-130a-3p regulates osimertinib resistance by targeting runt-related transcription factor 3 in lung adenocarcinoma. Sci Rep. 14:244292024. View Article : Google Scholar : PubMed/NCBI

Ni ZZ, He JK, Tang X, Tao Z, Zhang Y and Xie B: Identification of ELAVL1 gene and miRNA-139-3p involved in the aggressiveness of NSCLC. Eur Rev Med Pharmacol Sci. 24:9453–9464. 2020.PubMed/NCBI

Locati M, Curtale G and Mantovani A: Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 15:123–147. 2020. View Article : Google Scholar

Peng Y, Zhou M, Yang H, Qu R, Qiu Y, Hao J, Bi H and Guo D: Regulatory mechanism of M1/M2 macrophage polarization in the development of autoimmune diseases. Mediators Inflamm. 2023:88216102023. View Article : Google Scholar : PubMed/NCBI

Li SJ, Wang XH, Li LR, Chen L and Sun ZJ: Leveraging macrophage plasticity for precision-targeted tumor immunotherapy. Biochim Biophys Acta Mol Basis Dis. 1872:1681762026. View Article : Google Scholar : PubMed/NCBI

Zhang J, Zhou X and Hao H: Macrophage phenotype-switching in cancer. Eur J Pharmacol. 931:1752292022. View Article : Google Scholar : PubMed/NCBI

Zou Z, Lin H, Li M and Lin B: Tumor-associated macrophage polarization in the inflammatory tumor microenvironment. Front Oncol. 13:11031492023. View Article : Google Scholar : PubMed/NCBI

Goswami KK, Bose A and Baral R: Macrophages in tumor: An inflammatory perspective. Clin Immunol. 232:1088752021. View Article : Google Scholar : PubMed/NCBI

Gao J, Liang Y and Wang L: Shaping polarization of tumor-associated macrophages In cancer immunotherapy. Front Immunol. 13:8887132022. View Article : Google Scholar : PubMed/NCBI

Liang X, Bai R, Sun Y, Ma P, Lu X, Han T and Guan L: TAMs: Guardians or foes? Overcoming heterogeneity and delivery barriers for precision immunotherapy. Int Immunopharmacol. 163:1151952025. View Article : Google Scholar : PubMed/NCBI

Yang Y, Li S, To KKW, Zhu S, Wang F and Fu L: Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy. J Exp Clin Cancer Res. 44:1452025. View Article : Google Scholar : PubMed/NCBI

Saeed AF: Tumor-associated macrophages: Polarization, immunoregulation, and immunotherapy. Cells. 14:7412025. View Article : Google Scholar : PubMed/NCBI

Xu W, Zhao X, Daha MR and van Kooten C: Reversible differentiation of pro- and anti-inflammatory macrophages. Mol Immunol. 53:179–186. 2013. View Article : Google Scholar

Yang L, Shao Y, Zhang Z, Li Y, Wang F and Yu H: Metabolic insights into TAMs and the tumor immune microenvironment: Regulatory mechanisms and therapeutic interventions. Biochim Biophys Acta Rev Cancer. 1880:1894112025. View Article : Google Scholar : PubMed/NCBI

Ni Z, Zhou S, Zhang Y, Wang X, Yang H, Zhou H and Tao Z: THOC3 interacts with epithelial-to-mesenchymal transition to promote non-small cell lung cancer carcinoma progression through STAT3 signaling pathway. Transl Oncol. 67:1027412026. View Article : Google Scholar : PubMed/NCBI

Li X, Chen Z, Ni Y, Bian C, Huang J, Chen L, Xie X and Wang J: Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer. Transl Lung Cancer Res. 10:1338–1354. 2021. View Article : Google Scholar : PubMed/NCBI

Mi L, Xu L, Chen Z and Zheng Y: The influence of CXCL9 on M2 macrophages in lung cancer development. Transl Cancer Res. 14:8965–8978. 2025. View Article : Google Scholar

Lu CS, Shiau AL, Su BH, Hsu TS, Wang CT, Su YC, Tsai MS, Feng YH, Tseng YL, Yen YT, et al: Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer. J Hematol Oncol. 13:622020. View Article : Google Scholar : PubMed/NCBI

Ahmad A, Tiwari RK, Almeleebia TM, Al Fayi MS, Alshahrani MY, Ahmad I, Abohassan MS, Saeed M and Ansari IA: Swertia chirayita suppresses the growth of non-small cell lung cancer A549 cells and concomitantly induces apoptosis via downregulation of JAK1/STAT3 pathway. Saudi J Biol Sci. 28:6279–6288. 2021. View Article : Google Scholar : PubMed/NCBI

Hsiao YJ, Hsieh MS, Chang GC, Hsu YC, Wang CY, Chen YM, Chen YL, Yang PC and Yu SL: Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects. Cell Death Dis. 16:382025. View Article : Google Scholar : PubMed/NCBI

Kiran BK, Siddesh BM, Sherapura A, Thirusangu P, Vijay Avin BR, Vigneshwaran V, Kumaraswamy HM, Suchetha Kumari N, Pramod SN and Prabhakar BT: Allium sativum lectin as an immunotherapeutic agent: Eliciting IFN-γ production via 'M1' macrophage polarization to trigger JAK1/STAT1 and DDR mediated lung cancer cell death. Int J Biol Macromol. 330:1480762025. View Article : Google Scholar

Hao D and Chen S: Targeting tumor-associated macrophages in non-small cell lung cancer: Mechanisms, prognosis, and therapeutic opportunities. Front Immunol. 16:16795372025. View Article : Google Scholar : PubMed/NCBI

Yang FR, Li HL, Hu XW, Fu R, Li XR and Li HJ: Chinese herbal compound xiaoliu pingyi recipe inhibits the growth of lung adenocarcinoma by regulating the tumor vascular microenvironment. Integr Cancer Ther. 23:153473542412739622024. View Article : Google Scholar : PubMed/NCBI

Zhou Y, Ren D, Bi H, Yi B, Zhang C, Wang H and Sun J: Tumor-associated macrophage: Emerging targets for modulating the tumor microenvironment. Zhongguo Fei AI Za Zhi. 27:231–240. 2024.In Chinese. PubMed/NCBI

Brown JM, Recht L and Strober S: The promise of targeting macrophages in cancer therapy. Clin Cancer Res. 23:3241–3250. 2017. View Article : Google Scholar : PubMed/NCBI

Orlichenko LS and Radisky DC: Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis. 25:593–600. 2008. View Article : Google Scholar : PubMed/NCBI

Wei K, Ma Z, Yang F, Zhao X, Jiang W, Pan C, Li Z, Pan X, He Z, Xu J, et al: M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942. Cancer Lett. 526:205–216. 2022. View Article : Google Scholar

Gao W, Wang R, Yang S, Shi Y, Cui M, Jiang R, Li R, Yu Y, Jia D and Che D: MS4A1 regulates M1-polarized tumor-associated macrophage infiltration, angiogenesis, and cancer progression through the HIPPO pathway in lung adenocarcinoma. Cancer Immunol Immunother. 74:3562025. View Article : Google Scholar : PubMed/NCBI

Dhayalan S, Ramarajyam G, Mohanprasanth A, Muruhesan D, Rajendiran S and Arjunan S: Trigonelline suppresses the tumor progression via STAT2 signalling pathway in non-small cell lung carcinoma. Med Oncol. 43:1742026. View Article : Google Scholar : PubMed/NCBI

Ma WP, Hu SM, Xu YL, Li HH, Ma XQ, Wei BH, Li FY, Guan HS, Yu GL, Liu M and Liu HB: Haimufang decoction, a chinese medicine formula for lung cancer, arrests cell cycle, stimulates apoptosis in NCI-H1975 cells, and induces M1 polarization in RAW 264.7 macrophage cells. BMC Complement Med Ther. 20:2432020. View Article : Google Scholar : PubMed/NCBI

Zhu C, Zhang F, Li X, Xing D, Cai H, Wang X, Qu H, Li L and Zheng X: Isoginkgetin inhibits non-small cell lung cancer by inducing oxidative stress and regulating M1 macrophage polarization. Phytomedicine. 152:1578692026. View Article : Google Scholar : PubMed/NCBI

Cui L, Zhao S, Lu G, Zhang S, Zhang R, Zhou J and Yao Y: ACTL6A accelerates the progression of NSCLC through hippo/YAP signaling axis and TAMs-mediated immune regulation. Int Immunopharmacol. 168:1158282026. View Article : Google Scholar

Liu M, Wang T, Fu J, Cui T, Li N, Sun T, Liu J, Su C and Song B: Pinellia exosomal vesicles remodulate tumor-associated macrophage polarization via the serine synthesis/JAK/STAT signaling pathway to inhibit lung cancer growth. Phytomedicine. 151:1577592026. View Article : Google Scholar : PubMed/NCBI

Wang Q, Zhang Q, Wang X, Luo H, Du T, Wu L, Tan M, Chen Y, Wu X, Sun S, et al: TGM2-mediated autophagy contributes to the radio-resistance of non-small cell lung cancer stem-like cells. Biomedicines. 12:22312024. View Article : Google Scholar : PubMed/NCBI

Zhang X, Zhu M, Hong Z and Chen C: Co-culturing polarized M2 thp-1-derived macrophages enhance stemness of lung adenocarcinoma A549 cells. Ann Transl Med. 9:7092021. View Article : Google Scholar : PubMed/NCBI

Liu Y and Sun Y: TIPE2 inhibits the stemness of lung cancer cells by regulating the phenotypic polarization of tumor-associated macrophages. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 41:681–686. 2025.In Chinese.

Huang WC, Chan ML, Chen MJ, Tsai TH and Chen YJ: Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene. Oncotarget. 7:39363–39375. 2016. View Article : Google Scholar : PubMed/NCBI

Guo M, Li H, Zhao Z, Wang Y, Tang J, Zhong B and Zhao Y: Suppressive role of SCN4B in the epithelial-mesenchymal transition of lung adenocarcinoma. Oncol Rep. 55:682026. View Article : Google Scholar

Engur-Ozturk S and Dikmen M: Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: Assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c 'hydrocortisone-polarised' macrophages. Mol Biol Rep. 49:4777–4793. 2022. View Article : Google Scholar : PubMed/NCBI

Kawaguchi Y, Ohshio Y, Watanabe A, Shiratori T, Okamoto K, Ueda K, Kataoka Y, Suzuki T and Hanaoka J: Depletion of tumor-associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin. Cancer Sci. 114:751–763. 2023. View Article : Google Scholar

Liao L, Wang YX, Fan SS, Hu YY, Wang XC and Zhang X: The role and clinical significance of tumor-associated macrophages in the epithelial-mesenchymal transition of lung cancer. Front Oncol. 15:15715832025. View Article : Google Scholar : PubMed/NCBI

Hou Y, Li X, Zeng L and Zhang Y: SNHG16-loaded extracellular vesicles from hypoxic NSCLC cells drive M2 macrophage polarization to enhance cancer aggressiveness. Mol Immunol. 187:66–79. 2025. View Article : Google Scholar : PubMed/NCBI

Yang J, Wang X, Huang B, Liu R, Xiong H, Ye F, Zeng C, Fu X and Li L: An IFNγ/STAT1/JMJD3 axis induces ZEB1 expression and promotes aggressiveness in lung adenocarcinoma. Mol Cancer Res. 19:1234–1246. 2021. View Article : Google Scholar : PubMed/NCBI

Curtale G, Rubino M and Locati M: MicroRNAs as molecular switches in macrophage activation. Front Immunol. 10:7992019. View Article : Google Scholar : PubMed/NCBI

Saric A, Hipolito VEB, Kay JG, Canton J, Antonescu CN and Botelho RJ: mTOR controls lysosome tubulation and antigen presentation in macrophages and dendritic cells. Mol Biol Cell. 27:321–333. 2016. View Article : Google Scholar :

Wang L, Hu YY, Zhao JL, Huang F, Liang SQ, Dong L, Chen Y, Yu HC, Bai J, Yang JM, et al: Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression. J Immunother Cancer. 8:e0005172020. View Article : Google Scholar : PubMed/NCBI

Chirshev E, Oberg KC, Ioffe YJ and Unternaehrer JJ: Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer. Clin Transl Med. 8:242019. View Article : Google Scholar : PubMed/NCBI

Rong J, Xu L, Hu Y, Liu F, Yu Y, Guo H, Ni X, Huang Y, Zhao L and Wang Z: Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer. Cancer Cell Int. 20:4702020. View Article : Google Scholar : PubMed/NCBI

Jeong J, Hwang YE, Lee M, Keum S, Song S, Kim JW, Choi JH and Rhee S: Downregulation of AP1S1 causes the lysosomal degradation of EGFR in non-small cell lung cancer. J Cell Physiol. 238:2335–2347. 2023. View Article : Google Scholar : PubMed/NCBI

Liu L, Kou Z, Wang T, Shang Q, Zhang Q, Liu G, Ai J, Zhao Y and Sun C: Mechanism of non-small cell lung cancer-derived extracellular vesicle miRNA hsa-let-7b-5p targeting AP1S1 to regulate M2 macrophage polarization. Int J Genomics. 2026:82204782026. View Article : Google Scholar : PubMed/NCBI

Shi JH, Liu LN, Song DD, Liu WW, Ling C, Wu FX, Wang TT, Liu B, Cui NP, Qin Y and Ni ZY: TRAF3/STAT6 axis regulates macrophage polarization and tumor progression. Cell Death Differ. 30:2005–2016. 2023. View Article : Google Scholar : PubMed/NCBI

Diao H, Xu X, Zhao B and Yang G: miR-135a-5p inhibits tumor invasion by targeting ANGPT2 in gallbladder cancer. Mol Med Rep. 24:5282021. View Article : Google Scholar

Zhang H, Wang M, Lang Z, Liu H, Liu J and Ma L: MiR-135a-5p suppresses breast cancer cell proliferation, migration, and invasion by regulating BAG3. Clinics (Sao Paulo). 77:1001152022. View Article : Google Scholar : PubMed/NCBI

Gao HX, Liu MH, Fan M, Zhou JJ, Li AQ and Chen MW: MiR-135a-5p/STAT6-mediated EMT regulates IL-4 secretion in non-small cell lung cancer to affect M2-like TAM polarization. Int Immunopharmacol. 155:1146232025. View Article : Google Scholar : PubMed/NCBI

Zhang Z, Yang Y and Zhang X: MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer. Life Sci. 188:163–171. 2017. View Article : Google Scholar : PubMed/NCBI

Haupt M, Zechmeister B, Bosche B, Lieschke S, Zheng X, Zhang L, Venkataramani V, Jin F, Hein K, Weber MS, et al: Lithium enhances post-stroke blood-brain barrier integrity, activates the MAPK/ERK1/2 pathway and alters immune cell migration in mice. Neuropharmacology. 181:1083572020. View Article : Google Scholar : PubMed/NCBI

Liu J, Luo R, Wang J, Luan X, Wu D, Chen H, Hou Q, Mao G and Li X: Tumor cell-derived exosomal miR-770 inhibits M2 macrophage polarization via targeting MAP3K1 to inhibit the invasion of non-small cell lung cancer cells. Front Cell Dev Biol. 9:6796582021. View Article : Google Scholar : PubMed/NCBI

Ying H, Jin Y, Guo Y, Li Q, Ruan M, Zhu W, Yang C, Li Q and Zheng L: Long non-coding RNA NUT family member 2A-antisense RNA 1 sponges microRNA-613 to increase the resistance of gastric cancer cells to matrine through regulating oxidative stress and vascular endothelial growth factor A. Aging (Albany NY). 14:5153–5162. 2022. View Article : Google Scholar : PubMed/NCBI

Yang M, Zhou W, Xu M, Han X, Shi Y, Shi M and Wang Z: Tumor suppressor miR-613 alleviates non-small cell lung cancer cell via repressing M2 macrophage polarization. J Oncol. 2023:23112312023. View Article : Google Scholar : PubMed/NCBI

Almendros I, Khalyfa A, Trzepizur W, Gileles-Hillel A, Huang L, Akbarpour M, Andrade J, Farré R and Gozal D: Tumor cell malignant properties are enhanced by circulating exosomes in sleep apnea. Chest. 150:1031–1041. 2016. View Article : Google Scholar

Almendros I, Wang Y, Becker L, Lennon FE, Zheng J, Coats BR, Schoenfelt KS, Carreras A, Hakim F, Zhang SX, et al: Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea. Am J Respir Crit Care Med. 189:593–601. 2014. View Article : Google Scholar : PubMed/NCBI

Shan X, Zhang H, Zhang L, Zhou X, Wang T, Zhang J, Shu Y, Zhu W, Wen W and Liu P: Identification of four plasma microRNAs as potential biomarkers in the diagnosis of Male lung squamous cell carcinoma patients in China. Cancer Med. 7:2371–2381. 2018. View Article : Google Scholar

Ren J, Jin Z and Huang Y: Exosomal miR-106a-5p derived from intermittently hypoxic non-small-cell lung cancer increases tumor malignancy. Physiol Rep. 12:e161572024. View Article : Google Scholar : PubMed/NCBI

He G, Peng X, Wei S, Yang S, Li X, Huang M, Tang S, Jin H, Liu J, Zhang S, et al: Exosomes in the hypoxic TME: From release, uptake and biofunctions to clinical applications. Mol Cancer. 21:192022. View Article : Google Scholar : PubMed/NCBI

He B, You L, Uematsu K, Zang K, Xu Z, Lee AY, Costello JF, McCormick F and Jablons DM: SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci USA. 100:14133–14138. 2003. View Article : Google Scholar : PubMed/NCBI

Gu J, Yang S, Wang X, Wu Y, Wei J and Xu J: Hypoxic lung adenocarcinoma-derived exosomal miR-1290 induces M2 macrophage polarization by targeting SOCS3. Cancer Med. 12:12639–12652. 2023. View Article : Google Scholar : PubMed/NCBI

Zhu X, Guo Q, Zou J, Wang B, Zhang Z, Wei R, Zhao L, Zhang Y, Chu C, Fu X and Li X: MiR-19a-3p suppresses M1 macrophage polarization by inhibiting STAT1/IRF1 pathway. Front Pharmacol. 12:6140442021. View Article : Google Scholar : PubMed/NCBI

Dai L, Chen F, Zheng Y, Zhang D, Qian B, Ji H, Long F and Cretoiu D: miR-21 regulates growth and EMT in lung cancer cells via PTEN/akt/GSK3β signaling. Front Biosci. 24:1426–1439. 2019. View Article : Google Scholar

Jin J and Yu G: Hypoxic lung cancer cell-derived exosomal miR-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting IRF1. World J Surg Oncol. 20:2412022. View Article : Google Scholar : PubMed/NCBI

You G, Yang Q, Li X and Chen L: TMEM33, an oncogene regulated by miR-214-3p, promotes the progression of lung adenocarcinoma through the wnt/β-catenin signaling pathway. Oncol Res. 33:905–917. 2025. View Article : Google Scholar

Zhu S and Liao B: Mechanism of hypoxia-induced exosome circ_0051799 regulating the progression of lung adenocarcinoma. Biol Chem. 405:143–160. 2024. View Article : Google Scholar

Lee J, Park HY, Kim WW, Lee SJ, Jeong JH, Kang SH, Jung JH and Chae YS: Biological function of long noncoding RNA snaR in HER2-positive breast cancer cells. Tumour Biol J. 39:10104283177073742017.

Nakaoka HJ, Hara T, Yoshino S, Kanamori A, Matsui Y, Shimamura T, Sato H, Murakami Y, Seiki M and Sakamoto T: NECAB3 promotes activation of hypoxia-inducible factor-1 during normoxia and enhances tumourigenicity of cancer cells. Sci Rep. 6:227842016. View Article : Google Scholar : PubMed/NCBI

Li Z, Feng C, Guo J, Hu X and Xie D: GNAS-AS1/miR-4319/NECAB3 axis promotes migration and invasion of non-small cell lung cancer cells by altering macrophage polarization. Funct Integr Genomics. 20:17–28. 2020. View Article : Google Scholar

Bernardo ME and Fibbe WE: Mesenchymal stromal cells: Sensors and switchers of inflammation. Cell Stem Cell. 13:392–402. 2013. View Article : Google Scholar : PubMed/NCBI

Poggi A, Varesano S and Zocchi MR: How to hit mesenchymal stromal cells and make the tumor microenvironment immunostimulant rather than immunosuppressive. Front Immunol. 9:2622018. View Article : Google Scholar : PubMed/NCBI

Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong W, Liao Y and Du J: High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer. 49:604–615. 2013. View Article : Google Scholar

Xi J, Huang Q, Wang L, Ma X, Deng Q, Kumar M, Zhou Z, Li L, Zeng Z, Young KH, et al: miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy. Oncogene. 37:3151–3165. 2018. View Article : Google Scholar : PubMed/NCBI

Ren W, Hou J, Yang C, Wang H, Wu S, Wu Y, Zhao X and Lu C: Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery. J Exp Clin Cancer Res. 38:622019. View Article : Google Scholar : PubMed/NCBI

Pitt JM, Kroemer G and Zitvogel L: Extracellular vesicles: Masters of intercellular communication and potential clinical interventions. J Clin Invest. 126:1139–1143. 2016. View Article : Google Scholar : PubMed/NCBI

Yang Q, Diamond MP and Al-Hendy A: The emerging role of extracellular vesicle-derived miRNAs: Implication in cancer progression and stem cell related diseases. J Clin Epigenetics. 2:132016.

Triner D and Shah YM: Hypoxia-inducible factors: A central link between inflammation and cancer. J Clin Invest. 126:3689–3698. 2016. View Article : Google Scholar : PubMed/NCBI

Akers JC, Ramakrishnan V, Kim R, Phillips S, Kaimal V, Mao Y, Hua W, Yang I, Fu CC, Nolan J, et al: miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients. J Neurooncol. 123:205–216. 2015. View Article : Google Scholar : PubMed/NCBI

Hsu YL, Hung JY, Chang WA, Jian SF, Lin YS, Pan YC, Wu CY and Kuo PL: Hypoxic lung-cancer-derived extracellular vesicle MicroRNA-103a increases the oncogenic effects of macrophages by targeting PTEN. Mol Ther. 26:568–581. 2018. View Article : Google Scholar : PubMed/NCBI

Xu P, Xiao H, Yang Q, Hu R, Jiang L, Bi R, Jiang X, Wang L, Mei J, Ding F and Huang J: The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer. Exp Mol Med. 52:41–55. 2020. View Article : Google Scholar : PubMed/NCBI

Dong Z, Liu H and Zhao G: Long noncoding RNA SNHG6 promotes proliferation and inhibits apoptosis in non-small cell lung cancer cells by regulating miR-490-3p/RSF1 axis. Cancer Biother Radiopharm. 35:351–361. 2020.PubMed/NCBI

Brown S, Banfill K, Aznar MC, Whitehurst P and Faivre Finn C: The evolving role of radiotherapy in non-small cell lung cancer. Br J Radiol. 92:201905242019. View Article : Google Scholar : PubMed/NCBI

Abdolvand M, Chermahini ZM, Bahaloo S, Emami MH, Fahim A, Rahimi H, Amjadi E, Maghool F, Rohani F, Dadkhah M, et al: New long noncoding RNA biomarkers and ceRNA networks on miR-616-3p in colorectal cancer: Bioinformatics-based study. J Res Med Sci. 29:102024. View Article : Google Scholar : PubMed/NCBI

Song S, Zhao Y, Fu T, Fan Y, Tang J, Wang X, Liu C and Chen X: ELANE promotes M2 macrophage polarization by down-regulating PTEN and participates in the lung cancer progression. Immunol Invest. 52:21–34. 2023. View Article : Google Scholar

Chen T, Liu Y, Li C, Xu C, Ding C, Chen J and Zhao J: Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN/PI3K/AKT pathway to promote non-small cell lung cancer metastasis. Cancer Treat Res Commun. 28:1004122021.PubMed/NCBI

Yang L, Zhang Z, Zhang Y, Wang L, Zheng S, Li Y, Du D, Yuan C, Li H, Zeng Z, et al: Radiotherapy promotes M2 polarization of macrophages through the regulation of the PTEN/PI3K/AKT signaling pathway through miR-616-3p in lung cancer cell-derived exosomes. In Vitro Cell Dev Biol Anim. 61:1202–1217. 2025. View Article : Google Scholar : PubMed/NCBI

Baba Y, Nomoto D, Okadome K, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N and Baba H: Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma. Cancer Sci. 111:3132–3141. 2020. View Article : Google Scholar : PubMed/NCBI

Wang NH, Lei Z, Yang HN, Tang Z, Yang MQ, Wang Y, Sui JD and Wu YZ: Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: A narrative review. Ann Transl Med. 10:14062022. View Article : Google Scholar

Xu L, Li K, Li J, Xu F, Liang S, Kong Y and Chen B: The crosstalk between lung adenocarcinoma cells and M2 macrophages promotes cancer cell development via the SFRS1/miR-708-5p/PD-L1 axis. Life Sci. 371:1235992025. View Article : Google Scholar : PubMed/NCBI

Hu JL, Wang W, Lan XL, Zeng ZC, Liang YS, Yan YR, Song FY, Wang FF, Zhu XH, Liao WJ, et al: CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Mol Cancer. 18:912019. View Article : Google Scholar : PubMed/NCBI

Zhang D and Yang N: MiR-335-5p inhibits cell proliferation, migration and invasion in colorectal cancer through downregulating LDHB. J BUON. 24:1128–1136. 2019.PubMed/NCBI

Yu Y and Ren K: Five long non-coding RNAs establish a prognostic nomogram and construct a competing endogenous RNA network in the progression of non-small cell lung cancer. BMC Cancer. 21:4572021. View Article : Google Scholar : PubMed/NCBI

Skehel PA, Fabian-Fine R and Kandel ER: Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc Natl Acad Sci USA. 97:1101–1106. 2000. View Article : Google Scholar : PubMed/NCBI

Chen J, Sun JJ, Ma YW, Zhu MQ, Hu J, Lu QJ and Cai ZG: Cancer-associated fibroblasts derived exosomal LINC01833 promotes the occurrence of non-small cell lung cancer through miR-335-5p-VAPA axis. J Biochem Mol Toxicol. 38:e237692024. View Article : Google Scholar

Zhai Y, Liu Y, Wang Z, Wang W, Zhou J and Lu J: Long non-coding RNA LINC00313 accelerates cervical carcinoma progression by miR-4677-3p/CDK6 axis. OncoTargets Ther. 14:2213–2226. 2021. View Article : Google Scholar

Chen H, Wahafu P, Wang L and Chen X: LncRNA LINC00313 knockdown inhibits tumorigenesis and metastasis in human osteosarcoma by upregulating FOSL2 through sponging miR-342-3p. Yonsei Med J. 61:359–370. 2020. View Article : Google Scholar : PubMed/NCBI

Dang QQ, Li PH, Wang J, Zhao JY, Zhai SN, Zheng YJ and Yang DK: CircMAN1A2 contributes to nasopharyngeal carcinoma progression via enhancing the ubiquitination of ATMIN through miR-135a-3p/UBR5 axis. Hum Cell. 36:657–675. 2023. View Article : Google Scholar : PubMed/NCBI

Kong W, Zhang L, Chen Y, Yu Z and Zhao Z: Cancer cell-derived exosomal LINC00313 induces M2 macrophage differentiation in non-small cell lung cancer. Clin Transl Oncol. 24:2395–2408. 2022. View Article : Google Scholar : PubMed/NCBI

Ding J, Wang X, Yang H, Zhang L, Ying Y, Pi W, Deng G and Zhu Y: IGF2BP3 Triggers STAT3 pathway by stabilizing SRC RNA in an m6A-Dependent manner to promote lymphatic metastasis in LUAD. Cancer Sci. 116:936–950. 2025. View Article : Google Scholar : PubMed/NCBI

Chen J, Zhang K, Zhi Y, Wu Y, Chen B, Bai J and Wang X: Tumor-derived exosomal miR-19b-3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via hippo pathway. Clin Transl Med. 11:e4782021. View Article : Google Scholar : PubMed/NCBI

Lu GJ, Cui J, Qian Q, Hou ZB, Xie HY, Hu W, Hao KK, Xia N and Zhang Y: Overexpression of hsa_circ_0001715 is a potential diagnostic and prognostic biomarker in lung adenocarcinoma. Onco Targets Ther. 13:10775–10783. 2020. View Article : Google Scholar : PubMed/NCBI

Liao J, Chen Z, Luo X, Su Y, Huang T, Xu H, Lin K, Zheng Q, Zhang L, Lin G and Lin X: Hsa_circ_0006692 promotes lung cancer progression via miR-205-5p/CDK19 axis. Genes (Basel). 13:8462022. View Article : Google Scholar : PubMed/NCBI

Chen M, Cao C and Ma J: Tumor-related exosomal circ_0001715 promotes lung adenocarcinoma cell proliferation and metastasis via enhancing M2 macrophage polarization by regulating triggering receptor expressed on myeloid cells-2. Thorac Cancer. 15:227–238. 2024. View Article : Google Scholar :

Stawowczyk M, Wellenstein MD, Lee SB, Yomtoubian S, Durrans A, Choi H, Narula N, Altorki NK, Gao D and Mittal V: Matrix metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor. Neoplasia. 19:55–64. 2017. View Article : Google Scholar :

Ji F, Du R, Chen T, Zhang M, Zhu Y, Luo X and Ding Y: Circular RNA circSLC26A4 accelerates cervical cancer progression via miR-1287-5p/HOXA7 axis. Mol Ther Nucleic Acids. 19:413–420. 2020. View Article : Google Scholar : PubMed/NCBI

Qian J, Li J, Ma H and Ji W: Exosomal circ-ADRM1 promotes lung adenocarcinoma progression and induces macrophage M2 polarization through regulating MMP14 mRNA and protein. Anticancer Drugs. 34:333–343. 2023. View Article : Google Scholar

Jin M, Li L, Xu C, Wen Y and Zhao M: Estrogenic activities of two synthetic pyrethroids and their metabolites. J Environ Sci (China). 22:291–296. 2010. View Article : Google Scholar

Cai X, Yin Y, Li N, Zhu D, Zhang J, Zhang CY and Zen K: Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155. J Mol Cell Biol. 4:341–343. 2012. View Article : Google Scholar : PubMed/NCBI

Huang F, Chen Z, Chen H, Lu W, Xie S, Meng QH, Wu Y and Xia D: Cypermethrin promotes lung cancer metastasis via modulation of macrophage polarization by targeting MicroRNA-155/Bcl6. Toxicol Sci. 163:454–465. 2018. View Article : Google Scholar : PubMed/NCBI

Larhammar M, Huntwork-Rodriguez S, Rudhard Y, Sengupta-Ghosh A and Lewcock JW: The Ste20 family kinases MAP4K4, MINK1, and TNIK converge to regulate stress-induced JNK signaling in neurons. J Neurosci. 37:11074–11084. 2017. View Article : Google Scholar : PubMed/NCBI

Hao J, Hu Y, Li Y, Zhou Q and Lv X: Involvement of JNK signaling in IL4-induced M2 macrophage polarization. Exp Cell Res. 357:155–162. 2017. View Article : Google Scholar : PubMed/NCBI

Ma Y, Pan X, Xu P, Mi Y, Wang W, Wu X, He Q, Liu X, Tang W and An HX: Plasma microRNA alterations between EGFR-activating mutational NSCLC patients with and without primary resistance to TKI. Oncotarget. 8:88529–88536. 2017. View Article : Google Scholar : PubMed/NCBI

Xu L, Wang L, Yang R, Li T and Zhu X: Lung adenocarcinoma cell-derived exosomes promote M2 macrophage polarization through transmission of miR-3153 to activate the JNK signaling pathway. Hum Mol Genet. 32:2162–2176. 2023. View Article : Google Scholar : PubMed/NCBI

Li Y, Li Y, Liu J, Fan Y, Li X, Dong M, Liu H and Chen J: Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer. Cancer Biol Ther. 17:272–279. 2016. View Article : Google Scholar : PubMed/NCBI

Yuan Y, Guo L and Guo S: Exosomal miR-10b promotes invasion and epithelial-mesenchymal transformation of lung adenocarcinoma A549 cells by regulating macrophage M2 polarization. Zhongguo Fei Ai Za Zhi. 25:835–842. 2022.In Chinese.

Li Y, Zhao L, Shi B, Ma S, Xu Z, Ge Y, Liu Y, Zheng D and Shi J: Functions of miR-146a and miR-222 in tumor-associated macrophages in breast cancer. Sci Rep. 5:186482015. View Article : Google Scholar : PubMed/NCBI

Yin C, Han Q, Xu D, Zheng B, Zhao X and Zhang J: SALL4-mediated upregulation of exosomal miR-146a-5p drives T-cell exhaustion by M2 tumor-associated macrophages in HCC. Oncoimmunology. 8:16014792019. View Article : Google Scholar : PubMed/NCBI

Yan Z, Wen JX, Cao XS, Zhao W, Han YL, Wen XH, Yan L, Zhang M, Wang YF, Hai L, et al: Tumor cell-derived exosomal microRNA-146a promotes non-small cell lung cancer cell invasion and proliferation by inhibiting M1 macrophage polarization. Ann Transl Med. 10:13072022. View Article : Google Scholar

Jiang K, Yang J, Guo S, Zhao G, Wu H and Deng G: Peripheral circulating exosome-mediated delivery of miR-155 as a novel mechanism for acute lung inflammation. Mol Ther J. 27:1758–1771. 2019. View Article : Google Scholar

Lu L, McCurdy S, Huang S, Zhu X, Peplowska K, Tiirikainen M, Boisvert WA and Garmire LX: Time series miRNA-mRNA integrated analysis reveals critical miRNAs and targets in macrophage polarization. Sci Rep. 6:374462016. View Article : Google Scholar : PubMed/NCBI

Hsin JP, Lu Y, Loeb GB, Leslie CS and Rudensky AY: The effect of cellular context on miR-155-mediated gene regulation in four major immune cell types. Nat Immunol. 19:1137–1145. 2018. View Article : Google Scholar : PubMed/NCBI

Liu Y, Lu M, Liu F, Xu G, Feng C, Chen Y, Cai D, Sun H, Zeng Y, Xie J, et al: Extracellular vesicles obtained from lung adenocarcinoma cells cultured under intermittent hypoxia induce M2 macrophage polarization via miR-20a-5p delivery. Technol Cancer Res Treat. 23:153303382312194152024. View Article : Google Scholar : PubMed/NCBI

Lin G, Lin L, Chen X, Chen L, Yang J, Chen Y, Qian D, Zeng Y and Xu Y: PPAR-γ/NF-kB/AQP3 axis in M2 macrophage orchestrates lung adenocarcinoma progression by upregulating IL-6. Cell Death Dis. 15:5322024. View Article : Google Scholar

Courau T, Jaszczak RG, Samad B, Flynn E, Chew NW, Reeder GC, Tsui J, Teklu S, Pass LF, Edwards AW, et al: Differential assembly of mouse and human tumor microenvironments. Nat Immunol. 27:1282–1293. 2026. View Article : Google Scholar :

Raffo-Romero A, Ziane-Chaouche L, Salomé-Desnoulez S, Hajjaji N, Fournier I, Salzet M and Duhamel M: A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses. Cell Rep Methods. 4:1007922024. View Article : Google Scholar : PubMed/NCBI

de la Rosa C, Kendirli A, Baygün S, Bauernschmitt F, Thomann AS, Kisioglu I, Beckmann D, Carpentier Solorio Y, Pfaffenstaller V, Tai YH, et al: In vivo CRISPR screen reveals regulation of macrophage states in neuroinflammation. Nat Neurosci. 29:493–509. 2026. View Article : Google Scholar :

Liu H, Shi X, Wang D, Zhang H, Xu Z and Tan Z: Three-dimensional-printed In vitro model of colorectal cancer with immune microenvironment and reprogramming capabilities. ACS Biomater Sci Eng. 11:5991–6003. 2025. View Article : Google Scholar : PubMed/NCBI

Shang W, Lai C, Luo S and Chen L: Murine models of lung adenocarcinoma: Valuable tools for preclinical investigation. Gene. 971:1498022025. View Article : Google Scholar : PubMed/NCBI

Li J, Dhilipkannah P, Holden VK, Sachdeva A, Todd NW and Jiang F: Dysregulation of lncRNA MALAT1 contributes to lung cancer in African americans by modulating the tumor immune microenvironment. Cancers (Basel). 16:18762024. View Article : Google Scholar : PubMed/NCBI

Alimohammadi M, Amani D, Adcock IM and Mortaz E: Dual role of mir-146a in non-small cell lung cancer progression: Molecular mechanisms and clinical potential. Cell Signal. 136:1121152025. View Article : Google Scholar : PubMed/NCBI

Boucher A, Klopfenstein N, Hallas WM, Skibbe J, Appert A, Jang SH, Pulakanti K, Rao S, Cowden Dahl KD and Dahl R: The miR-23a~27a~24-2 microRNA cluster promotes inflammatory polarization of macrophages. J Immunol. 206:541–553. 2021. View Article : Google Scholar

Zheng G and Chen Y, Wang Y, Huang Z, Chen W and Chen Y: circHIF1A/miR-486-5p/GRHL2 axis induces macrophage M2 polarization to accelerate lung adenocarcinoma progression. Int Immunopharmacol. 180:1166702026. View Article : Google Scholar : PubMed/NCBI

Shang M, Ni L, Shan X, Cui Y, Hu P, Ji Z, Shen L, Zhang Y, Zhou J, Bing Chen, et al: MTHFD2 reprograms macrophage polarization by inhibiting PTEN. Cell Rep. 42:1124812023. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Jiang WL, Yang JY, Huang J, Kang G, Hu HB and Xie S: Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo. J Cell Physiol. 234:18679–18687. 2019. View Article : Google Scholar : PubMed/NCBI

Shi H, Ji Y, Zhang D, Liu Y and Fang P: MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells. Biochem Biophys Res Commun. 465:125–130. 2015. View Article : Google Scholar : PubMed/NCBI

Abdelaal AM, Sohal IS, Iyer SG, Sudarshan K, Orellana EA, Ozcan KE, Dos Santos AP, Low PS and Kasinski AL: Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent. Mol Ther Nucleic Acids. 35:1021932024. View Article : Google Scholar : PubMed/NCBI

Pandey S and Yadav P: Exploring the therapeutic potential of microRNAs: Targeted gene regulation strategies for enhanced cancer therapy. J Genet Eng Biotechnol. 23:1005562025. View Article : Google Scholar : PubMed/NCBI

Gaponova S, Patutina O, Sen'kova A, Burakova E, Savin I, Markov A, Shmendel E, Maslov M, Stetsenko D, Vlassov V and Zenkova M: Single shot vs. Cocktail: A comparison of mono- and combinative application of miRNA-targeted mesyl oligonucleotides for efficient antitumor therapy. Cancers (Basel). 14:43962022. View Article : Google Scholar : PubMed/NCBI

Sato Y, Matsui H, Yamamoto N, Sato R, Munakata T, Kohara M and Harashima H: Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus. J Control Release. 266:216–225. 2017. View Article : Google Scholar : PubMed/NCBI